Getting The Deal Through logo
Getting The Deal Through

Corporate counsel Q&A: Stathis Mihos, Pfizer

Pharma - Features – 18 September 2018

As part of our ongoing series of interviews with in-house lawyers at international pharma companies, PLN caught up with Stathis Mihos – Pfizer’s legal director and Greece, Cyprus, Malta, Israel and Adriatic sub-cluster lead – to discuss the challenges of doing business in the region and the company’s unique approach to working with outside counsel.

Community Round-up: new partners at Dechert, McDermott, McCarter and Berger Singerman

Pharma - News – 18 September 2018

Law firms on both sides of the Atlantic hired new life sciences partners last week.

Australia passes law to protect against medicine shortages amid EpiPen drought

Pharma - News – 18 September 2018

The Australian government has amended the country’s drug regulation to require pharmaceutical companies to report any shortages of their products.

US Senate passes bipartisan opioid package

Pharma - News – 18 September 2018

The US Senate has passed a package of more than 70 bipartisan bills in an effort to tackle the country’s opioid crisis.

The PLN Round-up (18 September)

Pharma - The Round-up – 18 September 2018

News in brief from around the world… The past week has seen China approve Takeda’s £46 billion acquisition of Shire and Novartis sell off parts of its Sandoz portfolios to India’s Aurobindo. Meanwhile Gwyneth Paltrow’s Goop has settled a false advertising suit, the EMA and FDA have published the findings from a carcinogen study, and the British Medical Journal has criticised clinical trials compliance.

Genentech claims Samsung biosimilar infringes breast cancer drug patents

Pharma - News – 11 September 2018

US drugmaker Genentech has sued Samsung Bioepis in Delaware, claiming the Korean company’s biosimilar version of breast cancer treatment Herceptin infringes 21 of its patents.

Follow Getting the Deal Through for the latest updates on law and regulation worldwide

Follow us on LinkedIn